Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Glaucoma: Overview01:25

Glaucoma: Overview

Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
Sleep Apnea01:21

Sleep Apnea

Sleep apnea is a condition where breathing stops intermittently during sleep, often leading to significant health issues. Each episode can last from 10 to 20 seconds or more and is frequently accompanied by a brief arousal from sleep. This disturbance, largely unnoticed by the individual, can lead to severe daytime fatigue. Commonly, individuals seek help after being informed by their partners about loud snoring and noticeable breathing pauses during sleep.
The condition is more prevalent among...
Increased Intracranial Pressure ll: Pathophysiology01:29

Increased Intracranial Pressure ll: Pathophysiology

Increased intracranial pressure (ICP) refers to a potentially life-threatening rise in pressure inside the skull. This usually happens when there is a major change in the volume of brain tissue, blood, or cerebrospinal fluid (CSF) — the three components inside the skull. According to the Monro-Kellie doctrine, if the volume of one component increases, the volumes of the other components must decrease to maintain normal pressure. If this does not happen, ICP rises.The process often begins with...
Photoreceptors and Visual Pathways01:22

Photoreceptors and Visual Pathways

At the molecular level, visual signals trigger transformations in photopigment molecules, resulting in changes in the photoreceptor cell's membrane potential. The photon's energy level is denoted by its wavelength, with each specific wavelength of visible light associated with a distinct color. The spectral range of visible light, classified as electromagnetic radiation, spans from 380 to 720 nm. Electromagnetic radiation wavelengths exceeding 720 nm fall under the infrared category, whereas...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Five-Year Outcomes of First-Generation iStent Versus Hydrus Microstent Implantation Combined with Phacoemulsification in Patients with Open-Angle Glaucoma: A Prospective Non-Randomized Comparative Study.

Journal of clinical medicine·2026
Same author

Sutureless capsular bag-intraocular lens complex scleral fixation using iris retractors in eyes with crystalline lens subluxation: long-term outcome.

Scientific reports·2026
Same author

Long-Term Assessment of Intraocular Lens Stability, Tilt and Decentration Between Four-Point Scleral Fixation and Yamane Techniques.

Journal of clinical medicine·2026
Same author

An update on posterior-approach blepharoptosis surgery: Influence of clinical factors on surgical outcomes.

PloS one·2026
Same author

Intraoperative use of mixed reality (MR) in humans across surgical disciplines: a major review.

3D printing in medicine·2025
Same author

Long-term outcomes of nationwide coordinated neovascular AMD treatment: A study based on Polish national registry.

Acta ophthalmologica·2025

Related Experiment Video

Updated: Jul 16, 2026

Glaucoma-inducing Procedure in an In Vivo Rat Model and Whole-mount Retina Preparation
08:30

Glaucoma-inducing Procedure in an In Vivo Rat Model and Whole-mount Retina Preparation

Published on: March 12, 2016

The Pathophysiological Association Between Obstructive Sleep Apnea and Glaucoma: A Current Update.

Wojciech Mazurek1, Łukasz Mazurek2, Barbara Rękas-Mazurek1

  • 1Department of Ophthalmology, Military Institute of Medicine-National Research Institute, 04-141 Warsaw, Poland.

Journal of Clinical Medicine
|July 15, 2026
PubMed
Summary

Obstructive sleep apnea (OSA) may contribute to glaucoma development through chronic hypoxia and reduced ocular pressure. This relationship is crucial for understanding normal-tension glaucoma and warrants multidisciplinary ophthalmic screening.

Keywords:
chronic intermittent hypoxiacontinuous positive airway pressureglaucomalamina cribrosanormal-tension glaucomaobstructive sleep apneaocular perfusion pressure

More Related Videos

Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents
10:10

Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents

Published on: February 15, 2022

Related Experiment Videos

Last Updated: Jul 16, 2026

Glaucoma-inducing Procedure in an In Vivo Rat Model and Whole-mount Retina Preparation
08:30

Glaucoma-inducing Procedure in an In Vivo Rat Model and Whole-mount Retina Preparation

Published on: March 12, 2016

Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents
10:10

Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents

Published on: February 15, 2022

Area of Science:

  • Ophthalmology
  • Neurology
  • Sleep Medicine

Background:

  • Glaucoma is a leading cause of irreversible blindness.
  • Elevated intraocular pressure (IOP) is a key risk factor, but not the sole cause.
  • Systemic conditions like obstructive sleep apnea (OSA) are implicated in glaucoma pathogenesis.

Purpose of the Study:

  • To review the pathophysiological links between OSA and glaucoma.
  • To explore the role of mechanical and vascular theories in this relationship.
  • To highlight the relevance for normal-tension glaucoma.

Main Methods:

  • Literature review of current theories on glaucoma pathophysiology.
  • Analysis of mechanisms connecting OSA and glaucoma.
  • Examination of clinical relevance and early markers.

Main Results:

  • Chronic intermittent hypoxia and reduced ocular perfusion pressure are principal connecting mechanisms.
  • These factors trigger optic nerve head hypoxia, oxidative stress, and lamina cribrosa remodeling.
  • A vicious cycle compromises optic nerve axon metabolic support, particularly in normal-tension glaucoma.

Conclusions:

  • OSA-related mechanisms are significant contributors to glaucoma, especially normal-tension glaucoma.
  • Retinal nerve fiber layer thinning is an early indicator of optic nerve damage.
  • A multidisciplinary approach with ophthalmic screening for subclinical damage is recommended.